Artivion Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | Outperform |
9
|
$107.53 | $118.92 | 17.64% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$25.40 | $32.87 | 20.08% | 6 | $147.23B |
| BSX | Boston Scientific | Buy |
11
|
$73.17 | $70.14 | 12.07% | 6 | $107.55B |
| MDT | Medtronic | Outperform |
11
|
$79.74 | $92.47 | 19.76% | 21 | $105.54B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$231.55 | $284.47 | 19.84% | 8 | $67.64B |
| EW | Edwards Lifesciences Corp | Outperform |
11
|
$86.43 | $91.18 | 12.23% | 5 | $52.98B |
| 4543 | Terumo | Outperform |
18
|
¥5.63k | ¥4.97k | -9.46% | 0 | ¥3.76T |
| BAX | Baxter International Inc | Outperform |
17
|
$40.13 | $44.86 | 12.14% | 5 | $20.10B |
| SWAV | Shockwave Medical | Hold |
4
|
$330.00 | $239.91 | 1.52% | 6 | $12.34B |
| PEN | Penumbra | Outperform |
9
|
$204.41 | $258.62 | 40.43% | 14 | $7.85B |
| GETI B | Getinge AB | Outperform |
18
|
kr235.10 | kr226.10 | -3.02% | 3 | kr64.03B |
| MMSI | Merit Medical Systems | Outperform |
14
|
$73.78 | $89.25 | 19.27% | 0 | $4.27B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$28.34 | $46.60 | 53.49% | 4 | $2.23B |
| 688016 | Shanghai MicroPort Endovascula... | Buy |
18
|
¥174.88 | ¥238.98 | 34.95% | 0 | ¥14.47B |
| LMAT | LeMaitre Vascular | Outperform |
18
|
$65.46 | $59.86 | 6.94% | 0 | $1.42B |
| ATRC | AtriCure | Buy |
8
|
$23.17 | $55.00 | 146.01% | 6 | $1.12B |
| 1302 | LifeTech Scientific | Buy |
16
|
HK$1.68 | HK$2.97 | 45.24% | 0 | HK$8.24B |
| SILK | Silk Road Medical, Inc | Outperform |
7
|
$17.80 | $12.33 | 6.74% | 4 | $678.50M |
| AVR | Anteris Technologies Ltd | Buy |
10
|
$22.75 | $28.00 | 31.87% | 0 | $437.03M |
| ANGO | AngioDynamics | Buy |
8
|
$5.81 | $16.33 | 123.75% | 0 | $280.18M |
| ELUT | Elutia | Buy |
2
|
$3.94 | $0.00 | 26.90% | 0 | $78.32M |
| RUA | RUA Life Sciences |
0
|
£0.11 | £0.66 | 500.00% | 0 | £6.83M | |
| AVGR | Avinger | Outperform |
9
|
$3.73 | $5.00 | 34.05% | 0 | $5.92M |